Overview

Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the clinical cure rate (ratio of clinically cured patients to the total number of patients) of ceftobiprole medocaril versus a comparator in the treatment of patients with community-acquired pneumonia.
Phase:
Phase 3
Details
Lead Sponsor:
Basilea Pharmaceutica
Treatments:
Ceftobiprole
Ceftobiprole medocaril
Ceftriaxone
Cephalosporins
Linezolid